Ventura Clinical Trials   Report issue

For profit Phase 1
Founded: Ventura CA United States (2007)

Organization Overview

First Clinical Trial
2020
NCT04630847
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Ventura Clinical Trials

Active Ingredients

Drugs in Phase 1 Trials (1)

human fecal microbiota (Reybota) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Autism Spectrum Disorder (Phase 1)

Autistic Disorder (Phase 1)

Child Development Disorders, Pervasive (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1